Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential

Area of Science:

• Psychiatry
• Infectious Diseases
• Public Health

Background:

• Major Depressive Disorder (MDD) is a significant concern in Human Immunodeficiency Virus (HIV) patients.
• Understanding psychiatric comorbidity in this population is crucial for effective treatment and management.

Purpose of the Study:

• To determine the prevalence of psychiatric comorbidity among depressed HIV patients.
• To investigate the association between psychiatric comorbidity and illness severity in this cohort.

Main Methods:

• A multi-site randomized controlled trial assessed 304 HIV patients with current Major Depressive Disorder (MDD).
• The Mini-International Neuropsychiatric Interview was used to diagnose comorbid mood, anxiety, and substance use disorders.
• Baseline adherence, risk, and health measures were also evaluated.

Main Results:

• Complicated depressive illness was frequent: 49% had dysthymia, 62% had anxiety disorders, and 28% had substance use disorders.
• Psychiatric comorbidity was linked to more HIV symptoms and poorer mental health-related quality of life.
• Antiretroviral adherence did not differ based on comorbidity presence.

Conclusions:

• Chronic depression and psychiatric comorbidity are prevalent in HIV patients with MDD.
• This comorbidity is associated with increased HIV disease severity and diminished quality of life.
• Identifying and addressing comorbidity is vital for managing depression and improving outcomes in HIV-infected individuals.